Erasca
San Diego
About Erasca
Erasca develops oncology drugs intended to provide precision oncology options. The company's drugs are being developed through multiple discovery programs for undisclosed targets that are biological drivers of cancer and are pursuing additional opportunities for pipeline expansion through academic and biopharmaceutical collaborations, providing patients with new potential solutions to not just treat but cure cancer. Erasca was founded in 2018 and is headquartered in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $854.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2026)
- Ticker: nasdaq:ERAS
- Website: erasca.com
- Phone: (858) 465-6511
Industries & Categories
Biotechnology, Life Science, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/erasca-15767 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.